Recently published: "BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503739/
Not the same group or study as the thesis by Nicholas J. Clayton from Virginia Commenwealth University that was previously posted and used RVX-208. This new one used the pan-BET inhibitors I-BET151 and JQ1.
BearDownAZ